Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4,-tetrahydro-1-naphthalenol hydrochloride (AA-497) , a new potent bronchodilator
Inatomi, N.; Kuriki, H.; Kanno, M.; Kawazoe, K.; Nagawa, Y.; Miyata, T.; Takahama, K.; Kasé, Y.
Arzneimittel-Forschung 30(2): 276-285
1980
ISSN/ISBN: 0004-4172 PMID: 7378107 Document Number: 159434
Document emailed within 1 workday
Related Documents
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397Kubo, S.; Uesaka, I.; Matsubara, I.; Ishihara, T.; Kasé, Y. 1977: Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs Arzneimittel-Forschung 27(7): 1433-1439
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061
Beckett, P.R.; Llupiá, J.; Lumachi, B.; Roberts, D.J. 1984: Pharmacological studies with almagate, a potent new antacid compound Arzneimittel-Forschung 34(10a): 1367-1370
Nawrocka, W.; Rutkowska, M.; Szelag, A.; Barczyńska, J.; Kedzierska-Goździk, L.; Błaszczyk, F.; Dziwiszek, W. 1996: Synthesis and pharmacological properties of new derivatives of 4-methyl-5-oxalo-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2-one and beta-oxo-5-(4-methyl-1H-2,3,4,5-tetrahydro-1,5-benzodiazepin-2 -one)propionic acid Acta Poloniae Pharmaceutica 53(6): 425-430
Vollmer, K.O.; Koss, F.W. 1970: Synthesis of DL-trans-2-dimethylamino-i-phenyl-cyclohex-3-en-trans-1-carboxylic acid ethyl ester-(6-14C)-hydrochloride Arzneimittel-Forschung 20(8): 990-992
Librowski, T.; Nalepa, I.; Czarnecki, R.; Vetulani, J. 1994: The effect of (-)-4-(2-hydroxy-3(N-isopropylamino)-propoxyimino)-cis-carane on basal and forskolin-stimulated accumulation of cyclic AMP in the cerebral cortical slices of the rat Journal of Pharmacy and Pharmacology 46(5): 393-394
Székely, J.I.; Dunai-Kovács, Z.; Miglécz, E.; Polgár, K.; Török, K.; Földes, J.; Váradi, A.; Bános, C.; Karczag, I.; Tolna, J. 1987: Pharmacological and human studies with a highly potent opioid peptide, D-Met2, Pro5-enkephalinamide Polish Journal of Pharmacology and Pharmacy 39(5): 641-656
Lutsky, B.N.; Millonig, R.C.; Wojnar, R.J.; Free, C.A.; Devlin, R.G.; Varma, R.K.; Karanewsky, D.S. 1986: Androstene-17-thioketals. 2nd communication: pharmacological profiles of tipredane and (11 beta, 17 alpha)-17-(ethylthio)-9 alpha-fluoro-17-[2-(fluoroethyl)thio]-11 beta-hydroxy-androsta-1,4-dien-3-one, structurally novel 20-thiasteroids possessing potent and selective topical antiinflammatory activity Arzneimittel-Forschung 36(12): 1787-1795
Kobayashi, S.; Hasegawa, K.; Mori, M.; Takagi, H. 1970: Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol) Arzneimittel-Forschung 20(1): 43-46
Hullot, P.; Poudrel, J.M.; Muller, A.; Escale, R.; Rossi, J.C.; Girard, J.P.; Bonne, C. 1997: Synthesis and biochemical/pharmacological profile of the novel leukotriene B4 receptor antagonist sodium (1S*, 3S*)-1-hydroxy-3-[(3 R*S*,E)-3-hydroxy-7-phenyl-1-hepten-1-yl]-1-cyclohexane acetate Arzneimittel-Forschung 47(1): 51-58
D'Antonio, D.; Iacone, A.; Fioritoni, G.; Dell'Isola, M.; Mastropasqua, L.; Lobefalo, L.; De Nicola, G.C.; Paolone, V.; Di Gregorio, P.; Recchia, A. 1991: Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir) Journal of ChemoTherapy 3(3): 162-166
Friehe, H.; Ney, P. 1997: Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride Arzneimittel-Forschung 47(2): 132-144
Mantovani, P.; Impicciatore, M. 1970: Some pharmacological activities of 2,6-bis-(hydroxymethyl)pyridin-bis-(N-methylcarbamate) (Pyridinolcarbamate) Il Farmaco; Edizione Scientifica 25(12): 912-919
Knoll, J.; Magyar, K.; Bánfi, D. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. IV. the fate of MZ-144 within the organism Arzneimittel-Forschung 21(5): 733-738
Hirotsu, I.; Kihara, T.; Nakamura, S.; Hattori, Y.; Hatta, M.; Kitakaze, Y.; Takahama, K.; Hashimoto, Y.; Miyata, T.; Ishihara, T. 1988: General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system Arzneimittel-Forschung 38(10): 1398-1409
Kubo, S.; Morikawa, K.; Matsubara, I.; Yamazaki, M.; Kato, H. 1981: Pharmacological studies of antispasmodics. III. Antispasmodic activity of 3-(di-2-thienylmethylene)-5-methyl-trans-quino-lizidinium bromide (HRS-902) on smooth muscle organs and its organ selectivity Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 77(1): 87-98
Knoll, J.; Fürst, S.; Mészáros, Z. 1971: The pharmacology of 1,6-dimethyl-3-carbethoxy-4-oxo-6,7,8,9-tetrahydro-homopyrimidazol-methylsulphate (MZ-144), a new, potent, non-narcotic analgesic. 3. Analysis of the central and peripheric effects Arzneimittel-Forschung 21(5): 727-733
Pahwa, G.S.; Anand, K.K.; Johri, S.; Gupta, S.; Atal, C.K. 1987: Pharmacological and toxicological investigations of 7-hydroxy-4-phenyl-3(4-hydroxy-phenyl)-coumarin (OV1) Indian Journal of Experimental Biology 25(7): 450-453
Vega, S.; Gil, M.S.; Darias, V.; Sanchez Mateo, C.C.; Exposito, M.A. 1995: Synthesis and pharmacological study of 5,6,8,9-tetrahydro-4H, 7H-pyrrolo[1,2-a]cyclopenta[b]thieno[3,2-f][1,4]diazepines Die Pharmazie 50(1): 27-33